Nosopharm receives €1 million loan to develop antibiotic candidate

A company dedicated to the research and development of new anti-infective drugs, Nosopharm, has received funding from Bpifrance worth €1 million in the form of an interest-free loan. Read more

14 Feb 2018 13:42 News